SlideShare a Scribd company logo
1 of 2
Pharmacotherapy. 2007 Apr;27(4):481-93.
Clinical pharmacy services, pharmacy staffing, and hospital
mortality rates.
Bond CA1, Raehl CL.
Author information
Abstract
OBJECTIVE:
To determine if hospital-based clinical pharmacy services and pharmacy staffing continue to be
associated with mortality rates.
METHODS:
A database was constructed from 1998 MedPAR, American Hospital Association's Annual Survey
of Hospitals, and National Clinical Pharmacy Services databases, consisting of data from
2,836,991 patients in 885 hospitals. Data from hospitals that had 14 clinical pharmacy services
were compared with data from hospitals that did not have these services; levels of hospital
pharmacist staffing were also compared. A multiple regression analysis, controlling for severity
of illness, was used.
RESULTS:
Seven clinical pharmacy services were associated with reduced mortality rates: pharmacist-
provided drug use evaluation (4491 reduced deaths, p=0.016), pharmacist-provided in-service
education (10,660 reduced deaths, p=0.037), pharmacist-provided adverse drug reaction
management (14,518 reduced deaths, p=0.012), pharmacist-provided drug protocol
management (18,401 reduced deaths, p=0.017), pharmacist participation on the
cardiopulmonary resuscitation team (12,880 reduced deaths, p=0.009), pharmacist participation
on medical rounds (11,093 reduced deaths, p=0.021), and pharmacist-provided admission drug
histories (3988 reduced deaths, p=0.001). Two staffing variables, number of pharmacy
administrators/100 occupied beds (p=0.037) and number of clinical pharmacists/100 occupied
beds (p=0.023), were also associated with reduced mortality rates.
CONCLUSION:
The number of clinical pharmacy services and staffing variables associated with reduced
mortality rates increased from two in 1989 to nine in 1998. The impact of clinical pharmacy on
mortality rates mandates consideration of a core set of clinical pharmacy services to be offered
in United States hospitals. These results have important implications for health care in general,
as well as for our profession and discipline.

More Related Content

What's hot

J. pub health luisetto m, ghulam r m. research article intensive care units t...
J. pub health luisetto m, ghulam r m. research article intensive care units t...J. pub health luisetto m, ghulam r m. research article intensive care units t...
J. pub health luisetto m, ghulam r m. research article intensive care units t...M. Luisetto Pharm.D.Spec. Pharmacology
 
PROJECT REPORT HIMANSHU
PROJECT REPORT HIMANSHUPROJECT REPORT HIMANSHU
PROJECT REPORT HIMANSHUhimanshu jain
 
Editorial clinical pharmacist active role in registrative clinical trials m.l...
Editorial clinical pharmacist active role in registrative clinical trials m.l...Editorial clinical pharmacist active role in registrative clinical trials m.l...
Editorial clinical pharmacist active role in registrative clinical trials m.l...M. Luisetto Pharm.D.Spec. Pharmacology
 
Internal 2013 - General practice clinical systems
Internal 2013 - General practice clinical systemsInternal 2013 - General practice clinical systems
Internal 2013 - General practice clinical systemsEvangelos Kontopantelis
 
Quality evaluation of community pharmacy blood pressure (BP) screening servic...
Quality evaluation of community pharmacy blood pressure (BP) screening servic...Quality evaluation of community pharmacy blood pressure (BP) screening servic...
Quality evaluation of community pharmacy blood pressure (BP) screening servic...RavinaBarrett
 
Steps and impact of pharmaceutical care and clinical pharmacy development on ...
Steps and impact of pharmaceutical care and clinical pharmacy development on ...Steps and impact of pharmaceutical care and clinical pharmacy development on ...
Steps and impact of pharmaceutical care and clinical pharmacy development on ...M. Luisetto Pharm.D.Spec. Pharmacology
 
Indian j medres1262167-2621692_071656
Indian j medres1262167-2621692_071656Indian j medres1262167-2621692_071656
Indian j medres1262167-2621692_071656Susmit Jain
 
Editorial new and old pharmacological anticoagulant strategies. m.luisetto 2...
Editorial new and old pharmacological anticoagulant strategies.  m.luisetto 2...Editorial new and old pharmacological anticoagulant strategies.  m.luisetto 2...
Editorial new and old pharmacological anticoagulant strategies. m.luisetto 2...M. Luisetto Pharm.D.Spec. Pharmacology
 
Clinical pharmaceutical care a new management health care discipline in 2016 ...
Clinical pharmaceutical care a new management health care discipline in 2016 ...Clinical pharmaceutical care a new management health care discipline in 2016 ...
Clinical pharmaceutical care a new management health care discipline in 2016 ...M. Luisetto Pharm.D.Spec. Pharmacology
 
An open letter to all clinical pharmacists 2016 pharmaceutical care medical l...
An open letter to all clinical pharmacists 2016 pharmaceutical care medical l...An open letter to all clinical pharmacists 2016 pharmaceutical care medical l...
An open letter to all clinical pharmacists 2016 pharmaceutical care medical l...M. Luisetto Pharm.D.Spec. Pharmacology
 
Submit20your20 powerpoint20file20here joynerr12_attempt_2012-12-06-02-08-37_j...
Submit20your20 powerpoint20file20here joynerr12_attempt_2012-12-06-02-08-37_j...Submit20your20 powerpoint20file20here joynerr12_attempt_2012-12-06-02-08-37_j...
Submit20your20 powerpoint20file20here joynerr12_attempt_2012-12-06-02-08-37_j...Xiaoming Zeng
 
Preprint review article letter to all pharmacist 2016 pharmaceutical care la...
Preprint review article letter to all pharmacist 2016 pharmaceutical care  la...Preprint review article letter to all pharmacist 2016 pharmaceutical care  la...
Preprint review article letter to all pharmacist 2016 pharmaceutical care la...M. Luisetto Pharm.D.Spec. Pharmacology
 
Luisetto m, ghulam r m. intensive care units the clinical pharmacist role to ...
Luisetto m, ghulam r m. intensive care units the clinical pharmacist role to ...Luisetto m, ghulam r m. intensive care units the clinical pharmacist role to ...
Luisetto m, ghulam r m. intensive care units the clinical pharmacist role to ...M. Luisetto Pharm.D.Spec. Pharmacology
 
Ehr And Pharmacy
Ehr And PharmacyEhr And Pharmacy
Ehr And Pharmacyrrogala
 
Development and validation of questionnaire for the assessment of pharmaceuti...
Development and validation of questionnaire for the assessment of pharmaceuti...Development and validation of questionnaire for the assessment of pharmaceuti...
Development and validation of questionnaire for the assessment of pharmaceuti...Alexander Decker
 
Luisetto m logistics ict systems and clinical pharmaceutical care strategies...
Luisetto m  logistics ict systems and clinical pharmaceutical care strategies...Luisetto m  logistics ict systems and clinical pharmaceutical care strategies...
Luisetto m logistics ict systems and clinical pharmaceutical care strategies...M. Luisetto Pharm.D.Spec. Pharmacology
 

What's hot (20)

J. pub health luisetto m, ghulam r m. research article intensive care units t...
J. pub health luisetto m, ghulam r m. research article intensive care units t...J. pub health luisetto m, ghulam r m. research article intensive care units t...
J. pub health luisetto m, ghulam r m. research article intensive care units t...
 
BMSL
BMSLBMSL
BMSL
 
PROJECT REPORT HIMANSHU
PROJECT REPORT HIMANSHUPROJECT REPORT HIMANSHU
PROJECT REPORT HIMANSHU
 
Editorial clinical pharmacist active role in registrative clinical trials m.l...
Editorial clinical pharmacist active role in registrative clinical trials m.l...Editorial clinical pharmacist active role in registrative clinical trials m.l...
Editorial clinical pharmacist active role in registrative clinical trials m.l...
 
AAPM REPORT 84 TG 43
AAPM REPORT 84 TG 43AAPM REPORT 84 TG 43
AAPM REPORT 84 TG 43
 
Internal 2013 - General practice clinical systems
Internal 2013 - General practice clinical systemsInternal 2013 - General practice clinical systems
Internal 2013 - General practice clinical systems
 
Quality evaluation of community pharmacy blood pressure (BP) screening servic...
Quality evaluation of community pharmacy blood pressure (BP) screening servic...Quality evaluation of community pharmacy blood pressure (BP) screening servic...
Quality evaluation of community pharmacy blood pressure (BP) screening servic...
 
Steps and impact of pharmaceutical care and clinical pharmacy development on ...
Steps and impact of pharmaceutical care and clinical pharmacy development on ...Steps and impact of pharmaceutical care and clinical pharmacy development on ...
Steps and impact of pharmaceutical care and clinical pharmacy development on ...
 
Indian j medres1262167-2621692_071656
Indian j medres1262167-2621692_071656Indian j medres1262167-2621692_071656
Indian j medres1262167-2621692_071656
 
Editorial new and old pharmacological anticoagulant strategies. m.luisetto 2...
Editorial new and old pharmacological anticoagulant strategies.  m.luisetto 2...Editorial new and old pharmacological anticoagulant strategies.  m.luisetto 2...
Editorial new and old pharmacological anticoagulant strategies. m.luisetto 2...
 
Clinical pharmaceutical care a new management health care discipline in 2016 ...
Clinical pharmaceutical care a new management health care discipline in 2016 ...Clinical pharmaceutical care a new management health care discipline in 2016 ...
Clinical pharmaceutical care a new management health care discipline in 2016 ...
 
An open letter to all clinical pharmacists 2016 pharmaceutical care medical l...
An open letter to all clinical pharmacists 2016 pharmaceutical care medical l...An open letter to all clinical pharmacists 2016 pharmaceutical care medical l...
An open letter to all clinical pharmacists 2016 pharmaceutical care medical l...
 
Submit20your20 powerpoint20file20here joynerr12_attempt_2012-12-06-02-08-37_j...
Submit20your20 powerpoint20file20here joynerr12_attempt_2012-12-06-02-08-37_j...Submit20your20 powerpoint20file20here joynerr12_attempt_2012-12-06-02-08-37_j...
Submit20your20 powerpoint20file20here joynerr12_attempt_2012-12-06-02-08-37_j...
 
Preprint review article letter to all pharmacist 2016 pharmaceutical care la...
Preprint review article letter to all pharmacist 2016 pharmaceutical care  la...Preprint review article letter to all pharmacist 2016 pharmaceutical care  la...
Preprint review article letter to all pharmacist 2016 pharmaceutical care la...
 
Luisetto m, ghulam r m. intensive care units the clinical pharmacist role to ...
Luisetto m, ghulam r m. intensive care units the clinical pharmacist role to ...Luisetto m, ghulam r m. intensive care units the clinical pharmacist role to ...
Luisetto m, ghulam r m. intensive care units the clinical pharmacist role to ...
 
Ehr And Pharmacy
Ehr And PharmacyEhr And Pharmacy
Ehr And Pharmacy
 
Use of alternative medicine
Use of alternative medicineUse of alternative medicine
Use of alternative medicine
 
Development and validation of questionnaire for the assessment of pharmaceuti...
Development and validation of questionnaire for the assessment of pharmaceuti...Development and validation of questionnaire for the assessment of pharmaceuti...
Development and validation of questionnaire for the assessment of pharmaceuti...
 
Emergency med pharmacist 2017 coralic a. et al
Emergency med pharmacist 2017 coralic a. et alEmergency med pharmacist 2017 coralic a. et al
Emergency med pharmacist 2017 coralic a. et al
 
Luisetto m logistics ict systems and clinical pharmaceutical care strategies...
Luisetto m  logistics ict systems and clinical pharmaceutical care strategies...Luisetto m  logistics ict systems and clinical pharmaceutical care strategies...
Luisetto m logistics ict systems and clinical pharmaceutical care strategies...
 

Viewers also liked

Project of clinical pharmacy in final year of pharmacy
Project of clinical pharmacy in final year of pharmacyProject of clinical pharmacy in final year of pharmacy
Project of clinical pharmacy in final year of pharmacyMUSHTAQ AHMED
 
Cost cutting in hospitals
Cost cutting in hospitalsCost cutting in hospitals
Cost cutting in hospitalsJosep Arroyo
 
Hospital pharmacy institiutional section
Hospital pharmacy institiutional sectionHospital pharmacy institiutional section
Hospital pharmacy institiutional sectionHoma Saad
 
Hospital pharmacy procedural manual
Hospital pharmacy procedural manualHospital pharmacy procedural manual
Hospital pharmacy procedural manualDevyani Joshi
 
Hospital pharmacy management
Hospital pharmacy managementHospital pharmacy management
Hospital pharmacy managementArmin Eisazaei
 
Hospital Pharmacy
Hospital PharmacyHospital Pharmacy
Hospital PharmacyNc Das
 
Acknowledgement
AcknowledgementAcknowledgement
Acknowledgementkaranj212
 
Sample Acknowledgement of Project Report
Sample Acknowledgement of Project ReportSample Acknowledgement of Project Report
Sample Acknowledgement of Project ReportMBAnetbook.co.in
 
Acknowledgement For Assignment
Acknowledgement For AssignmentAcknowledgement For Assignment
Acknowledgement For AssignmentThomas Mon
 

Viewers also liked (15)

Project of clinical pharmacy in final year of pharmacy
Project of clinical pharmacy in final year of pharmacyProject of clinical pharmacy in final year of pharmacy
Project of clinical pharmacy in final year of pharmacy
 
Cost cutting in hospitals
Cost cutting in hospitalsCost cutting in hospitals
Cost cutting in hospitals
 
Hospital pharmacy institiutional section
Hospital pharmacy institiutional sectionHospital pharmacy institiutional section
Hospital pharmacy institiutional section
 
Hospital pharmacy procedural manual
Hospital pharmacy procedural manualHospital pharmacy procedural manual
Hospital pharmacy procedural manual
 
Pharmacy services
Pharmacy servicesPharmacy services
Pharmacy services
 
Maintenance, Management & Planning of Hospital Facilities
Maintenance, Management & Planning of Hospital FacilitiesMaintenance, Management & Planning of Hospital Facilities
Maintenance, Management & Planning of Hospital Facilities
 
Hospital pharmacy management
Hospital pharmacy managementHospital pharmacy management
Hospital pharmacy management
 
Hospital pharmacy service
Hospital pharmacy serviceHospital pharmacy service
Hospital pharmacy service
 
Introduction to hospital pharmacy
Introduction to hospital pharmacyIntroduction to hospital pharmacy
Introduction to hospital pharmacy
 
Hospital Pharmacy
Hospital PharmacyHospital Pharmacy
Hospital Pharmacy
 
Acknowledgement
AcknowledgementAcknowledgement
Acknowledgement
 
Sample Acknowledgement of Project Report
Sample Acknowledgement of Project ReportSample Acknowledgement of Project Report
Sample Acknowledgement of Project Report
 
Clinical pharmacy
Clinical pharmacyClinical pharmacy
Clinical pharmacy
 
Acknowledgement
AcknowledgementAcknowledgement
Acknowledgement
 
Acknowledgement For Assignment
Acknowledgement For AssignmentAcknowledgement For Assignment
Acknowledgement For Assignment
 

Similar to Articolo pharmacotherapy 2007 Bond et al 2007 clinical pharmacy service , pharmacy staffing, and hospital mortality rates n.66

Jpps luisetto m, mashori gr (2017) intensive care units the clinical pharmac...
Jpps luisetto m, mashori gr (2017) intensive care units  the clinical pharmac...Jpps luisetto m, mashori gr (2017) intensive care units  the clinical pharmac...
Jpps luisetto m, mashori gr (2017) intensive care units the clinical pharmac...M. Luisetto Pharm.D.Spec. Pharmacology
 
Genoa Pharmacy Med adherence & outcomes study
Genoa Pharmacy Med adherence & outcomes studyGenoa Pharmacy Med adherence & outcomes study
Genoa Pharmacy Med adherence & outcomes studyJohn Muilenburg
 
JAPhA Home Based MTM 2016
JAPhA Home Based MTM 2016JAPhA Home Based MTM 2016
JAPhA Home Based MTM 2016Toni Salvatore
 
Measuring to Improve Medication Reconciliationin a Large Sub.docx
Measuring to Improve Medication Reconciliationin a Large Sub.docxMeasuring to Improve Medication Reconciliationin a Large Sub.docx
Measuring to Improve Medication Reconciliationin a Large Sub.docxalfredacavx97
 
Medication Adherence and its Relationship to the Therapeutic Alliance
Medication Adherence and its Relationship to the Therapeutic AllianceMedication Adherence and its Relationship to the Therapeutic Alliance
Medication Adherence and its Relationship to the Therapeutic AllianceScott Miller
 
PRACTICE REPORT Medication safety effectiveness2218 Am J H.docx
PRACTICE REPORT Medication safety effectiveness2218 Am J H.docxPRACTICE REPORT Medication safety effectiveness2218 Am J H.docx
PRACTICE REPORT Medication safety effectiveness2218 Am J H.docxChantellPantoja184
 
The Effects of Nurse Staffing on Adverse Events, Morbidity, Mortality, and Me...
The Effects of Nurse Staffing on Adverse Events, Morbidity, Mortality, and Me...The Effects of Nurse Staffing on Adverse Events, Morbidity, Mortality, and Me...
The Effects of Nurse Staffing on Adverse Events, Morbidity, Mortality, and Me...Healthcare consultant
 
Podium Presentation Midwest Social and Administrative Conference,Chicago,2008
Podium Presentation Midwest Social and Administrative Conference,Chicago,2008Podium Presentation Midwest Social and Administrative Conference,Chicago,2008
Podium Presentation Midwest Social and Administrative Conference,Chicago,2008aramasa3
 
Scopus - clinical pharmacy services in AIDS
Scopus - clinical pharmacy services in AIDSScopus - clinical pharmacy services in AIDS
Scopus - clinical pharmacy services in AIDSrjwong6
 
Poster abstract 2019 national seminar on recent trends in radiopharmaceutical...
Poster abstract 2019 national seminar on recent trends in radiopharmaceutical...Poster abstract 2019 national seminar on recent trends in radiopharmaceutical...
Poster abstract 2019 national seminar on recent trends in radiopharmaceutical...M. Luisetto Pharm.D.Spec. Pharmacology
 
IMS Health Enriched Real-World Data Study
IMS Health Enriched Real-World Data StudyIMS Health Enriched Real-World Data Study
IMS Health Enriched Real-World Data StudyIMSHealthRWES
 
IMPACT STUDY_12NOV2015
IMPACT STUDY_12NOV2015IMPACT STUDY_12NOV2015
IMPACT STUDY_12NOV2015Kim Kersten
 
Nurse Staffing And Quality Of Careللطالب عامر آل الري
Nurse Staffing And  Quality Of Careللطالب عامر آل الريNurse Staffing And  Quality Of Careللطالب عامر آل الري
Nurse Staffing And Quality Of Careللطالب عامر آل الريTsega Tilahun
 
Adaptive method OR dosing with feedback
Adaptive method OR dosing with feedbackAdaptive method OR dosing with feedback
Adaptive method OR dosing with feedbackpavithra vinayak
 
Journal review of EHR use and benefits
Journal review of EHR use and benefitsJournal review of EHR use and benefits
Journal review of EHR use and benefitsJ. Don Soriano
 
Works Cited Milne, Anne C., Alison Avenell, and Jan Potter. Meta-.docx
Works Cited Milne, Anne C., Alison Avenell, and Jan Potter. Meta-.docxWorks Cited Milne, Anne C., Alison Avenell, and Jan Potter. Meta-.docx
Works Cited Milne, Anne C., Alison Avenell, and Jan Potter. Meta-.docxkeilenettie
 
A Ph A 2009 Poster
A Ph A 2009 PosterA Ph A 2009 Poster
A Ph A 2009 Posteraramasa3
 

Similar to Articolo pharmacotherapy 2007 Bond et al 2007 clinical pharmacy service , pharmacy staffing, and hospital mortality rates n.66 (20)

Jpps luisetto m, mashori gr (2017) intensive care units the clinical pharmac...
Jpps luisetto m, mashori gr (2017) intensive care units  the clinical pharmac...Jpps luisetto m, mashori gr (2017) intensive care units  the clinical pharmac...
Jpps luisetto m, mashori gr (2017) intensive care units the clinical pharmac...
 
Genoa Pharmacy Med adherence & outcomes study
Genoa Pharmacy Med adherence & outcomes studyGenoa Pharmacy Med adherence & outcomes study
Genoa Pharmacy Med adherence & outcomes study
 
JAPhA Home Based MTM 2016
JAPhA Home Based MTM 2016JAPhA Home Based MTM 2016
JAPhA Home Based MTM 2016
 
Measuring to Improve Medication Reconciliationin a Large Sub.docx
Measuring to Improve Medication Reconciliationin a Large Sub.docxMeasuring to Improve Medication Reconciliationin a Large Sub.docx
Measuring to Improve Medication Reconciliationin a Large Sub.docx
 
Medication Adherence and its Relationship to the Therapeutic Alliance
Medication Adherence and its Relationship to the Therapeutic AllianceMedication Adherence and its Relationship to the Therapeutic Alliance
Medication Adherence and its Relationship to the Therapeutic Alliance
 
PRACTICE REPORT Medication safety effectiveness2218 Am J H.docx
PRACTICE REPORT Medication safety effectiveness2218 Am J H.docxPRACTICE REPORT Medication safety effectiveness2218 Am J H.docx
PRACTICE REPORT Medication safety effectiveness2218 Am J H.docx
 
The Effects of Nurse Staffing on Adverse Events, Morbidity, Mortality, and Me...
The Effects of Nurse Staffing on Adverse Events, Morbidity, Mortality, and Me...The Effects of Nurse Staffing on Adverse Events, Morbidity, Mortality, and Me...
The Effects of Nurse Staffing on Adverse Events, Morbidity, Mortality, and Me...
 
Podium Presentation Midwest Social and Administrative Conference,Chicago,2008
Podium Presentation Midwest Social and Administrative Conference,Chicago,2008Podium Presentation Midwest Social and Administrative Conference,Chicago,2008
Podium Presentation Midwest Social and Administrative Conference,Chicago,2008
 
Scopus - clinical pharmacy services in AIDS
Scopus - clinical pharmacy services in AIDSScopus - clinical pharmacy services in AIDS
Scopus - clinical pharmacy services in AIDS
 
Poster abstract 2019 national seminar on recent trends in radiopharmaceutical...
Poster abstract 2019 national seminar on recent trends in radiopharmaceutical...Poster abstract 2019 national seminar on recent trends in radiopharmaceutical...
Poster abstract 2019 national seminar on recent trends in radiopharmaceutical...
 
IMS Health Enriched Real-World Data Study
IMS Health Enriched Real-World Data StudyIMS Health Enriched Real-World Data Study
IMS Health Enriched Real-World Data Study
 
Ari Refs
Ari RefsAri Refs
Ari Refs
 
IMPACT STUDY_12NOV2015
IMPACT STUDY_12NOV2015IMPACT STUDY_12NOV2015
IMPACT STUDY_12NOV2015
 
Nurse Staffing And Quality Of Careللطالب عامر آل الري
Nurse Staffing And  Quality Of Careللطالب عامر آل الريNurse Staffing And  Quality Of Careللطالب عامر آل الري
Nurse Staffing And Quality Of Careللطالب عامر آل الري
 
Adaptive method OR dosing with feedback
Adaptive method OR dosing with feedbackAdaptive method OR dosing with feedback
Adaptive method OR dosing with feedback
 
Patient Outcomes in Magnet Hospitals 5 26 11
Patient Outcomes in Magnet Hospitals 5 26 11Patient Outcomes in Magnet Hospitals 5 26 11
Patient Outcomes in Magnet Hospitals 5 26 11
 
Journal review of EHR use and benefits
Journal review of EHR use and benefitsJournal review of EHR use and benefits
Journal review of EHR use and benefits
 
Works Cited Milne, Anne C., Alison Avenell, and Jan Potter. Meta-.docx
Works Cited Milne, Anne C., Alison Avenell, and Jan Potter. Meta-.docxWorks Cited Milne, Anne C., Alison Avenell, and Jan Potter. Meta-.docx
Works Cited Milne, Anne C., Alison Avenell, and Jan Potter. Meta-.docx
 
A Ph A 2009 Poster
A Ph A 2009 PosterA Ph A 2009 Poster
A Ph A 2009 Poster
 
Adr project
Adr projectAdr project
Adr project
 

More from M. Luisetto Pharm.D.Spec. Pharmacology

Acceptance letter 25052 (1)-2 SUDDEN CARDIAC DEATHS BEFORE - AFTER COVID -19 ...
Acceptance letter 25052 (1)-2 SUDDEN CARDIAC DEATHS BEFORE - AFTER COVID -19 ...Acceptance letter 25052 (1)-2 SUDDEN CARDIAC DEATHS BEFORE - AFTER COVID -19 ...
Acceptance letter 25052 (1)-2 SUDDEN CARDIAC DEATHS BEFORE - AFTER COVID -19 ...M. Luisetto Pharm.D.Spec. Pharmacology
 
ICRJ-2-1071 Monoliths in the mRNA Vaccine Purification Process the Silica Res...
ICRJ-2-1071 Monoliths in the mRNA Vaccine Purification Process the Silica Res...ICRJ-2-1071 Monoliths in the mRNA Vaccine Purification Process the Silica Res...
ICRJ-2-1071 Monoliths in the mRNA Vaccine Purification Process the Silica Res...M. Luisetto Pharm.D.Spec. Pharmacology
 
Current Research in Vaccines ACCEPTATION LETTER m R.N.A. PURIFICATIONS PROCES...
Current Research in Vaccines ACCEPTATION LETTER m R.N.A. PURIFICATIONS PROCES...Current Research in Vaccines ACCEPTATION LETTER m R.N.A. PURIFICATIONS PROCES...
Current Research in Vaccines ACCEPTATION LETTER m R.N.A. PURIFICATIONS PROCES...M. Luisetto Pharm.D.Spec. Pharmacology
 
Graphene Derivates Carbon Products and Separation Properties : the M R.N.A. P...
Graphene Derivates Carbon Products and Separation Properties : the M R.N.A. P...Graphene Derivates Carbon Products and Separation Properties : the M R.N.A. P...
Graphene Derivates Carbon Products and Separation Properties : the M R.N.A. P...M. Luisetto Pharm.D.Spec. Pharmacology
 
m R.N.A. Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and ...
m R.N.A. Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and ...m R.N.A. Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and ...
m R.N.A. Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and ...M. Luisetto Pharm.D.Spec. Pharmacology
 
JOURNAL OF FORENSIC PATHOLOGY ARTICLE IN PRESS LUISETTO ET AL 2022.docx
JOURNAL OF FORENSIC PATHOLOGY ARTICLE IN PRESS LUISETTO ET AL 2022.docxJOURNAL OF FORENSIC PATHOLOGY ARTICLE IN PRESS LUISETTO ET AL 2022.docx
JOURNAL OF FORENSIC PATHOLOGY ARTICLE IN PRESS LUISETTO ET AL 2022.docxM. Luisetto Pharm.D.Spec. Pharmacology
 
Acceptance letter j. of forensic research OPAST - White paper on Covid- 19 a...
Acceptance letter j. of forensic research OPAST - White paper on  Covid- 19 a...Acceptance letter j. of forensic research OPAST - White paper on  Covid- 19 a...
Acceptance letter j. of forensic research OPAST - White paper on Covid- 19 a...M. Luisetto Pharm.D.Spec. Pharmacology
 
Raman (Rs) Spettroscopy for Biopharmaceutical Quality Control and Pat Raw Mat...
Raman (Rs) Spettroscopy for Biopharmaceutical Quality Control and Pat Raw Mat...Raman (Rs) Spettroscopy for Biopharmaceutical Quality Control and Pat Raw Mat...
Raman (Rs) Spettroscopy for Biopharmaceutical Quality Control and Pat Raw Mat...M. Luisetto Pharm.D.Spec. Pharmacology
 
WHITE PAPER - m RNA vaccine production Quality control- regulatory and toxic...
WHITE PAPER - m RNA vaccine production Quality control-  regulatory and toxic...WHITE PAPER - m RNA vaccine production Quality control-  regulatory and toxic...
WHITE PAPER - m RNA vaccine production Quality control- regulatory and toxic...M. Luisetto Pharm.D.Spec. Pharmacology
 
SWJPS-Graphene and Derivates Physico-Chemical and Toxicology Properties in th...
SWJPS-Graphene and Derivates Physico-Chemical and Toxicology Properties in th...SWJPS-Graphene and Derivates Physico-Chemical and Toxicology Properties in th...
SWJPS-Graphene and Derivates Physico-Chemical and Toxicology Properties in th...M. Luisetto Pharm.D.Spec. Pharmacology
 
MENTAL ENERGY cover image by ALESSANDRA FALEGGI-Authors luisetto M et al 202...
MENTAL ENERGY cover image by ALESSANDRA FALEGGI-Authors luisetto M et  al 202...MENTAL ENERGY cover image by ALESSANDRA FALEGGI-Authors luisetto M et  al 202...
MENTAL ENERGY cover image by ALESSANDRA FALEGGI-Authors luisetto M et al 202...M. Luisetto Pharm.D.Spec. Pharmacology
 
ACCEPTATION LETTER SWJPS Review comment Form (swjps-1-107) Graphene and Deri...
ACCEPTATION LETTER SWJPS Review  comment Form (swjps-1-107) Graphene and Deri...ACCEPTATION LETTER SWJPS Review  comment Form (swjps-1-107) Graphene and Deri...
ACCEPTATION LETTER SWJPS Review comment Form (swjps-1-107) Graphene and Deri...M. Luisetto Pharm.D.Spec. Pharmacology
 
IMA 2022 Marijnskaya certificate GRAPHENE and DERIVATES chemico -physical ...
IMA  2022 Marijnskaya certificate GRAPHENE and  DERIVATES  chemico -physical ...IMA  2022 Marijnskaya certificate GRAPHENE and  DERIVATES  chemico -physical ...
IMA 2022 Marijnskaya certificate GRAPHENE and DERIVATES chemico -physical ...M. Luisetto Pharm.D.Spec. Pharmacology
 
EDITORIAL GRAPHENE and DERIVATES CHEMICO-PHYSICAL AND TOXICOLOGICAL PROPERT...
EDITORIAL  GRAPHENE and DERIVATES  CHEMICO-PHYSICAL AND TOXICOLOGICAL PROPERT...EDITORIAL  GRAPHENE and DERIVATES  CHEMICO-PHYSICAL AND TOXICOLOGICAL PROPERT...
EDITORIAL GRAPHENE and DERIVATES CHEMICO-PHYSICAL AND TOXICOLOGICAL PROPERT...M. Luisetto Pharm.D.Spec. Pharmacology
 
Pdf Book -GRAPHENE and DERIVATES PHYSICO- CHEMICAL AND TOXICOLOGY properti...
Pdf Book -GRAPHENE and  DERIVATES  PHYSICO- CHEMICAL  AND TOXICOLOGY properti...Pdf Book -GRAPHENE and  DERIVATES  PHYSICO- CHEMICAL  AND TOXICOLOGY properti...
Pdf Book -GRAPHENE and DERIVATES PHYSICO- CHEMICAL AND TOXICOLOGY properti...M. Luisetto Pharm.D.Spec. Pharmacology
 
Sars-cov2 Spike protein and derivates toxicology :fertility and teratogen eva...
Sars-cov2 Spike protein and derivates toxicology :fertility and teratogen eva...Sars-cov2 Spike protein and derivates toxicology :fertility and teratogen eva...
Sars-cov2 Spike protein and derivates toxicology :fertility and teratogen eva...M. Luisetto Pharm.D.Spec. Pharmacology
 
Luisetto M ND agosto 2022 estratto in lingua italiana pubb. 05-08-2022 GRA...
Luisetto M  ND agosto 2022 estratto in lingua italiana pubb. 05-08-2022   GRA...Luisetto M  ND agosto 2022 estratto in lingua italiana pubb. 05-08-2022   GRA...
Luisetto M ND agosto 2022 estratto in lingua italiana pubb. 05-08-2022 GRA...M. Luisetto Pharm.D.Spec. Pharmacology
 

More from M. Luisetto Pharm.D.Spec. Pharmacology (20)

Acceptance letter 25052 (1)-2 SUDDEN CARDIAC DEATHS BEFORE - AFTER COVID -19 ...
Acceptance letter 25052 (1)-2 SUDDEN CARDIAC DEATHS BEFORE - AFTER COVID -19 ...Acceptance letter 25052 (1)-2 SUDDEN CARDIAC DEATHS BEFORE - AFTER COVID -19 ...
Acceptance letter 25052 (1)-2 SUDDEN CARDIAC DEATHS BEFORE - AFTER COVID -19 ...
 
Teoria del libro PLUS IMAGO- PHILOSOPHIA ET SCIENTIA
Teoria del libro PLUS IMAGO- PHILOSOPHIA ET SCIENTIA  Teoria del libro PLUS IMAGO- PHILOSOPHIA ET SCIENTIA
Teoria del libro PLUS IMAGO- PHILOSOPHIA ET SCIENTIA
 
Mauro Luisetto Abstract Acceptance Letter.pdf
Mauro Luisetto Abstract Acceptance Letter.pdfMauro Luisetto Abstract Acceptance Letter.pdf
Mauro Luisetto Abstract Acceptance Letter.pdf
 
Teoria del libro PLUS IMAGO- PHILOSOPHIA ET SCIENTIA.pdf
Teoria del libro PLUS IMAGO- PHILOSOPHIA ET SCIENTIA.pdfTeoria del libro PLUS IMAGO- PHILOSOPHIA ET SCIENTIA.pdf
Teoria del libro PLUS IMAGO- PHILOSOPHIA ET SCIENTIA.pdf
 
ICRJ-2-1071 Monoliths in the mRNA Vaccine Purification Process the Silica Res...
ICRJ-2-1071 Monoliths in the mRNA Vaccine Purification Process the Silica Res...ICRJ-2-1071 Monoliths in the mRNA Vaccine Purification Process the Silica Res...
ICRJ-2-1071 Monoliths in the mRNA Vaccine Purification Process the Silica Res...
 
Current Research in Vaccines ACCEPTATION LETTER m R.N.A. PURIFICATIONS PROCES...
Current Research in Vaccines ACCEPTATION LETTER m R.N.A. PURIFICATIONS PROCES...Current Research in Vaccines ACCEPTATION LETTER m R.N.A. PURIFICATIONS PROCES...
Current Research in Vaccines ACCEPTATION LETTER m R.N.A. PURIFICATIONS PROCES...
 
Graphene Derivates Carbon Products and Separation Properties : the M R.N.A. P...
Graphene Derivates Carbon Products and Separation Properties : the M R.N.A. P...Graphene Derivates Carbon Products and Separation Properties : the M R.N.A. P...
Graphene Derivates Carbon Products and Separation Properties : the M R.N.A. P...
 
m R.N.A. Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and ...
m R.N.A. Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and ...m R.N.A. Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and ...
m R.N.A. Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and ...
 
JOURNAL OF FORENSIC PATHOLOGY ARTICLE IN PRESS LUISETTO ET AL 2022.docx
JOURNAL OF FORENSIC PATHOLOGY ARTICLE IN PRESS LUISETTO ET AL 2022.docxJOURNAL OF FORENSIC PATHOLOGY ARTICLE IN PRESS LUISETTO ET AL 2022.docx
JOURNAL OF FORENSIC PATHOLOGY ARTICLE IN PRESS LUISETTO ET AL 2022.docx
 
Acceptance letter j. of forensic research OPAST - White paper on Covid- 19 a...
Acceptance letter j. of forensic research OPAST - White paper on  Covid- 19 a...Acceptance letter j. of forensic research OPAST - White paper on  Covid- 19 a...
Acceptance letter j. of forensic research OPAST - White paper on Covid- 19 a...
 
Raman (Rs) Spettroscopy for Biopharmaceutical Quality Control and Pat Raw Mat...
Raman (Rs) Spettroscopy for Biopharmaceutical Quality Control and Pat Raw Mat...Raman (Rs) Spettroscopy for Biopharmaceutical Quality Control and Pat Raw Mat...
Raman (Rs) Spettroscopy for Biopharmaceutical Quality Control and Pat Raw Mat...
 
WHITE PAPER - m RNA vaccine production Quality control- regulatory and toxic...
WHITE PAPER - m RNA vaccine production Quality control-  regulatory and toxic...WHITE PAPER - m RNA vaccine production Quality control-  regulatory and toxic...
WHITE PAPER - m RNA vaccine production Quality control- regulatory and toxic...
 
SWJPS-Graphene and Derivates Physico-Chemical and Toxicology Properties in th...
SWJPS-Graphene and Derivates Physico-Chemical and Toxicology Properties in th...SWJPS-Graphene and Derivates Physico-Chemical and Toxicology Properties in th...
SWJPS-Graphene and Derivates Physico-Chemical and Toxicology Properties in th...
 
MENTAL ENERGY cover image by ALESSANDRA FALEGGI-Authors luisetto M et al 202...
MENTAL ENERGY cover image by ALESSANDRA FALEGGI-Authors luisetto M et  al 202...MENTAL ENERGY cover image by ALESSANDRA FALEGGI-Authors luisetto M et  al 202...
MENTAL ENERGY cover image by ALESSANDRA FALEGGI-Authors luisetto M et al 202...
 
ACCEPTATION LETTER SWJPS Review comment Form (swjps-1-107) Graphene and Deri...
ACCEPTATION LETTER SWJPS Review  comment Form (swjps-1-107) Graphene and Deri...ACCEPTATION LETTER SWJPS Review  comment Form (swjps-1-107) Graphene and Deri...
ACCEPTATION LETTER SWJPS Review comment Form (swjps-1-107) Graphene and Deri...
 
IMA 2022 Marijnskaya certificate GRAPHENE and DERIVATES chemico -physical ...
IMA  2022 Marijnskaya certificate GRAPHENE and  DERIVATES  chemico -physical ...IMA  2022 Marijnskaya certificate GRAPHENE and  DERIVATES  chemico -physical ...
IMA 2022 Marijnskaya certificate GRAPHENE and DERIVATES chemico -physical ...
 
EDITORIAL GRAPHENE and DERIVATES CHEMICO-PHYSICAL AND TOXICOLOGICAL PROPERT...
EDITORIAL  GRAPHENE and DERIVATES  CHEMICO-PHYSICAL AND TOXICOLOGICAL PROPERT...EDITORIAL  GRAPHENE and DERIVATES  CHEMICO-PHYSICAL AND TOXICOLOGICAL PROPERT...
EDITORIAL GRAPHENE and DERIVATES CHEMICO-PHYSICAL AND TOXICOLOGICAL PROPERT...
 
Pdf Book -GRAPHENE and DERIVATES PHYSICO- CHEMICAL AND TOXICOLOGY properti...
Pdf Book -GRAPHENE and  DERIVATES  PHYSICO- CHEMICAL  AND TOXICOLOGY properti...Pdf Book -GRAPHENE and  DERIVATES  PHYSICO- CHEMICAL  AND TOXICOLOGY properti...
Pdf Book -GRAPHENE and DERIVATES PHYSICO- CHEMICAL AND TOXICOLOGY properti...
 
Sars-cov2 Spike protein and derivates toxicology :fertility and teratogen eva...
Sars-cov2 Spike protein and derivates toxicology :fertility and teratogen eva...Sars-cov2 Spike protein and derivates toxicology :fertility and teratogen eva...
Sars-cov2 Spike protein and derivates toxicology :fertility and teratogen eva...
 
Luisetto M ND agosto 2022 estratto in lingua italiana pubb. 05-08-2022 GRA...
Luisetto M  ND agosto 2022 estratto in lingua italiana pubb. 05-08-2022   GRA...Luisetto M  ND agosto 2022 estratto in lingua italiana pubb. 05-08-2022   GRA...
Luisetto M ND agosto 2022 estratto in lingua italiana pubb. 05-08-2022 GRA...
 

Articolo pharmacotherapy 2007 Bond et al 2007 clinical pharmacy service , pharmacy staffing, and hospital mortality rates n.66

  • 1. Pharmacotherapy. 2007 Apr;27(4):481-93. Clinical pharmacy services, pharmacy staffing, and hospital mortality rates. Bond CA1, Raehl CL. Author information Abstract OBJECTIVE: To determine if hospital-based clinical pharmacy services and pharmacy staffing continue to be associated with mortality rates. METHODS: A database was constructed from 1998 MedPAR, American Hospital Association's Annual Survey of Hospitals, and National Clinical Pharmacy Services databases, consisting of data from 2,836,991 patients in 885 hospitals. Data from hospitals that had 14 clinical pharmacy services were compared with data from hospitals that did not have these services; levels of hospital pharmacist staffing were also compared. A multiple regression analysis, controlling for severity of illness, was used. RESULTS: Seven clinical pharmacy services were associated with reduced mortality rates: pharmacist- provided drug use evaluation (4491 reduced deaths, p=0.016), pharmacist-provided in-service education (10,660 reduced deaths, p=0.037), pharmacist-provided adverse drug reaction management (14,518 reduced deaths, p=0.012), pharmacist-provided drug protocol management (18,401 reduced deaths, p=0.017), pharmacist participation on the cardiopulmonary resuscitation team (12,880 reduced deaths, p=0.009), pharmacist participation on medical rounds (11,093 reduced deaths, p=0.021), and pharmacist-provided admission drug histories (3988 reduced deaths, p=0.001). Two staffing variables, number of pharmacy administrators/100 occupied beds (p=0.037) and number of clinical pharmacists/100 occupied beds (p=0.023), were also associated with reduced mortality rates. CONCLUSION:
  • 2. The number of clinical pharmacy services and staffing variables associated with reduced mortality rates increased from two in 1989 to nine in 1998. The impact of clinical pharmacy on mortality rates mandates consideration of a core set of clinical pharmacy services to be offered in United States hospitals. These results have important implications for health care in general, as well as for our profession and discipline.